PCS BIOTECH

Process Control Solutions.
Dedicated to improving therapeutic protein CQAs.

Who we are

Located at Alderley Park, PCS Biotech is dedicated to Process Control Solutions for biotherapeutic development and manufacture. PCS Biotech have developed two pioneering products AccuCell® EQC and AccuCell® 360 to improve process control and product CQAs.

Our mission

Through scientific innovation, improve biotherapeutic quality, productivity and patient outcomes.

Monoclonal Antibody Therapeutics in Numbers

Lyu X, Zhao Q, The global landscape of approved antibody therapies. Antib Ther. 2022 Sep 6;5(4):233-257. doi: 10.1093/abt/tbac021. PMID: 36213257; PMCID: PMC9535261.

Approved therapies
0
Projected CAGR
0 %
2021 Market value
$ 0 B
2028 Projected
$ 0 B

Our technology

PCS Biotech developed the IMPERIUM™ platform technology to manufacture quality control standards that closely represent cell culture media samples. From IMPERIUM™, the AccuCell® range of external quality control standards (EQCs) were created to ensure accuracy of upstream analytical technology.

AccuCell® 360 software enables real-time data review and analysis of global facilities.

You can achieve

Efficient bioprocessing

Copyright © 2025 PCS Biotech Limited. All content on this website is protected by copyright law | PCS Biotech Limited is registered in England and Wales with company number 13291506. VAT No. 476 1661 70 | AccuCell and ACCUCELL are registered trademarks and property of PCS Biotech Limited.
All rights reserved.